email   Email Us: info@lupinepublishers.com phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2644-1381

Current Trends on Biostatistics & Biometrics

Research Article(ISSN: 2644-1381)

Prospective Applications of the Medicinal Desert Plant Rhazya stricta in Green Chemistry Genomics and Agriculture Biotechnology: Mini Review Volume 1 - Issue 5

Mohamed Nabih Baeshen1, Mohiuddin Khan Warsi2, Arwa A Makki2, Dina Hajjar2, Mohammad Azhar Kamal2, Ammar AL-Farga2* and Nabih A Baeshen3

  • 1Department of Biological Sciences, Faculty of Science, University of Jeddah, Saudi Arabia
  • 2Department of Biochemistry, Faculty of Science, University of Jeddah, Saudi Arabia
  • 3Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Saudi Arabia

Received: October 18, 2019;   Published: October 30, 2019

*Corresponding author: Ammar AL-Farga, Department of Biochemistry, Faculty of Science, University of Jeddah, Jeddah, Saudi Arabia

DOI: 10.32474/CTBB.2018.01.000125

Abstract PDF

Abstract

The medicinal desert shrub Rhazya stricta is a member of the Apocynaceae family. This plant is a local shrub, which mostly found around and within the valleys in desert lands. R. strictawas one of the famous medicinal plants in traditional and folkloric medicine. As well as to its medicinal properties, it’s also a promising plant in the field of bioengineering and the future of genetically modified corps according to its resistance biotic and biotic stress factors and its survival in the harsh desert conditions. The plant was used over history in many nations and prescribed to treat many infections, inflammations, and diseases. On the basis of various experimental validations, it’s been found that R. stricta has various chemotherapeutic properties such as, anti-cancer, anti-diabetic, and antibacterial effects, including. Future studies must concentrate on the chemoinformatics, bioengineering, natural product genomics and metabolomics of the plant. It can be concluded that R. strictais wealth resource for many cosmetic and pharmaceutical products and a solution for genetic modification of many corps according to its resistant genes to biotic and abiotic conditions.

Keywords: Rhazyastricta;Chemoinformatics; Bioengineering; Genomics; Bioinformatics; Metabolomics

Introduction

The leaves of R. strictacontain alkaloids, glycosides, triterpene and tannins and it is known to be a rich source of Indole Alkaloids. Indole alkaloids exhibit various biological activities such as antihypertensive, antimicrobial and antitumor properties and also shown as central nervous system stimulants[3].More than hundreds of alkaloids have been isolated and characterized from R. strictaleaves [4]stems, roots and legumes [5]. Still, a large number of alkaloids from R. stricta are not commercially available and their isolation is a challenging and time-consuming process. Khan et al demonstrated that organic alkaloid extracts of Rhazya stricta were showing the antibacterial property towards MERSA, and transmission electron microscopy was showing the Rhazya extract disrupt the cell membrane of MERSA.

In this study the antibacterial property was demonstrated by the well plate methods, the measured the size of the zone it was 9-16mm in range. Khan et al demonstrated that organic alkaloid extracts of Rhazya stricta were showing the antibacterial property towards MERSA, and transmission electron microscopy was showing the Rhazya extract disrupt the cell membrane of MERSA. In this study the antibacterial property was demonstrated by the well plate methods, the measured the size of the zone it was 9-16mm in range. The organic alkaloid extract of R. stricta was the most effective against E. Coli and MRSA, resulting in cell membrane disruption visible with transmission electron microscopy[6].

Genotoxicity is also one of the key characteristics that make it important as therapeutic shrubs after the antibacterial activity of Rhazya. When Baeshen et al administered a whole aqueous and alkaloid extract of Rhazya to rats by oral gavage the DNA damage was showing in RAPD. In finally the results were showing the genotoxicity and clastogenicity in rat leukocytes.In this context, Rhazya stricta Improves key biochemical parameters in mammals Baeshen et al found that alkaloids are isolated from R's aqueous and chemical extracts. Strict therapy has the potential to reduce triglycerides without affecting the function of the liver and kidneys[7].

Along with other potential approaches, the anti-cancerous property of Rhazya is a novel potential in the field of medical science. Various studied has been done in this field, regarding the justification of this point Baeshen et al demonstrates that the aqueous extract of Rhazya stricta obtained from leaves induced DNA damage, cell death, cytotoxicity. This concludes that the extract has anti-cancerous and mutagenicity property[3].Rhazya stricta crude extract has property has induced apoptosis[8].Indole alkaloids (tetrahydro sycamine and swearing) have great potential regarding anti-cancer activity[10].Rhazinilam is isolated alkaloid compounds from Rhazia stricta have great importance regarding various cancerous cell line at very low concentration [9,10]Rhazya stricta has a property of anticancer and antioxidant. In concern with cancer, breast cancer is a big issue. Every year it is spreading very rapidly and a prime cause of cancer death among women. In this regard, Baeshen et al reveal the anti-human breast cancer activity in Rhazya using in vitro methods. Ethanolic extract of Rhazya stricta inhibits the human breast cancer cell line MCF-7 and MDA-MB-231. They define the apoptosis by the loss of cell viability, proteolytic cleavage of polymers and chromatin condensation. They demonstrate that Bax/Bcl-2 ratio, low expression of human telomerase transcript and gene of cyclin D1.On behalf of above results Rhazya stricta showing anti human breast cancer activity[1]. Baeshen et al. demonstrated successfully the potential of Harmal's anti-cancer activity against human breast cancer cells in vitro and the mechanism of its activity. In which they found that the ethanol extract of Harmal potently inhibited the cellular growth of human breast cancer cell lines, MCF-7 and MDA-MB-231, in a dose-time dependent manner. Furthermore, it induced sequences of events marked by apoptosis, accompanied by a loss of cell viability, chromatin condensation, DNA fragmentation and proteolytic cleavage of poly (ADP-Ribose) polymerase. Harmal-dependent apoptotic mechanisms involved an increase in the Bax/Bcl-2 ratio and down-regulation of all c-myc, human telomerase reverse transcriptase, and cyclin D1 proteins. From these results, we conclude that Harmal exerts anti-proliferative action on breast cancer cells through apoptosis induction, and that it may be a potentially effective chemo preventive or therapeutic agent against breast cancer[1].

Combine effect of crude alkaloid (CAERS) and flavonoid (CFEZO) extracts prepared from medicinal herbs, Rhazya strictaand Zingiberofficinale, respectively, on the growth of human GBM cell line, U251 induced apoptosis. Combination of Rhazya strictaand Zingiberofficinalehas potential to induce apoptosis mediated by PARP-1 cleavage, down regulation of cyclin D1 and I creased the expression of p53 and p21 [11].

Rhazya has anti-cancer properties as well as anti-diabetic properties. Rhazya has anti-diabetic potential along with anticancer as well. Baeshen et al show that alkaloids, flavonoids, tannins, and Rhazya stricta triterpene extract contain anti-diabetes mellitus properties. They also show that the leaf extract of Rhazya, when administered orally to streptozotocin-treated rats, increases the level of insulin and reduces the level of plasma glucose[1,3,4,12,13].Ali et al. reveal that the stringent Rhazya also has an impact on CNS. High dose of Rhazya showed the CNS depressing property as different researchers conclude that this depressing property may be caused by the presence of β-carboline ring in the molecules obtained from Rhazya extract[14,15].This study is an attempt to gather Rhazya data that havebeen grown in KSA. As far as our knowledge is concerned, however, there are few literary works related to studying Rhazya as a Mini Review.

Future prospects of Rhazya Molecules

Faisal et al have demonstrated that a chloroform extract of Rhazya stricta has potential in neurodegenerative diseases. It helps in neuronal differentiation at the initial stage. Pleuripotency markers (TRA-1-60, Klf4, Oct4, Sox2) were showing the down regulation under the treatment of alkaloid extract[16].Nano formulation is also important steps to control the pathogenic microbes in this context Ahmed et al demonstrated the gold nano particles by the leaves of Rhazya strictaDecne was effective against Leishmania Tropicaand Staphylococcus aureus[17]. The ability of humans and other mammalian species to combat a wide array of potentially invasive bacterial species depends, in part, on diverse cellular and humoral antibacterial innate immune systems[24].

Harmal extract Rhazimaninehinders metastasis and encourages apoptosis by down regulating Bcl-2 gene in vitro in breast cancer as well as in colon cancer, which is mediated by inhibition of NFkB and activator protein-1. Rhazya stricta extract also exhibit antioxidant, inhibits colony-formation capacity and cell cycle custody. Many researchers use these Rhazya stricta compounds as a novel potential anti-tumor agent in different treatments for cancer[16,18,19].

To understand the chemical /physiochemical properties of Rhazia stricta molecules which obtain from extract will open the new vista of Rhazya compounds for their biological activity. In this regard, we predict the biological activity of a modified Rhazya compound using different commercial / public domain sarwar that may increase compound activity. Scientific community trying to identify molecules founds in Rhazya extract and study of molecules considered as future prospects of Rhazya stricta target and drug classification based using the commercial and public domain[20]. Swiss Target Prediction [21]. In hopes of creating better access to protein crystallization, researchers are doing to develop algorithms and hardware devices [22].

The discovery of Rhazya as therapeutic potential for various diseases since more than 100 alkaloids and non-alkaloids have been reported, but still we are not able to understand the uses of these compounds as a drug. Keeping with the view of the above facts various research groups trying to utilize the identified Rhazya compound as a modified form using various Chemoinformatics techniques and predicts the biological activity of new compounds. Site-driven mutagenesis based on polymerase chain reaction (PCR) is an invaluable technique to alter genes and therefore the structure and activity of individual proteins in a systematic manner, opening up opportunities to investigate protein structure-function relationships, enzyme specificity and selectivity, or protein engineering[23].

Rhazya stricta is easily available in Arabia and South Asia and act as folk medicines so it is worth to understand at the level of the chemical, computational and synthetic point of view. Baeshen et al work on known compounds of antimicrobial Rhazia, namely Tetrahydrosecamine, Rhazimanine, Akuammidine and Stemmadenine(Tables 1- 4).

Using different Chemoinformatics tool targets of antimicrobial compounds in human cells will predict and study most similar drugs. In our computational information focus on Yohimbin compound because in our selected antimicrobial compound Yohimbin is the highly similar drug for the entire compound. 20,21 Tetrahydrosecamine were targeting 73% membrane receptor, 13% enzymes (Acetylcholinesterase and Cholinesterase) while 13% target were showing unclassified. Tetrahydrosecamine is also showing similarity with Bacampicillin:It’s a pro drug of ampicillin used by oral administration, absorbed in the gastrointestinal tract and hydrolyzed by the action of esterases in the intestinal wall. It has an antibacterial property using the mechanism to inhibit the biosynthesis of cell wall. It's applicable in the treatment of urinary tract and respiratory tract infections. In this context computational drug classification on the basis of drug similarity, maybe Tetrahydrosecamine has also the same mechanism of action of antimicrobial. Tetrahydrosecamine has also similarity with Pivampicillin and Pivmecillinam both have antimicrobial activity using the mechanism action of inhibition of cell wall synthesis [24].

Conclusion

Rhazya stricta is folk medicinal herbs have various pharmacological significance. In the past people were using as directly herbs, parts leaves, root and stem. In the present the chemical molecules of the herbs obtained after isolation and extraction of alkaloid and non-alkaloid have various biological activities (antimicrobial, antioxidant, antifungal, anti-inflammatory, hypertension, metabolic and CNS). In the future may be the scientific community need to change the native alkaloid structure using various server studies described in this article. Tables 1-4 reveals that the natural occurring Indole alkaloids possess not only those characteristics which are reported, but also, they have a various target prediction and drug (FDA approved) similar by chemoinformatically. In this context, the researcher will design the new drugs based on Indole alkaloids of a slight modification of the side chain of Rhazya stricta's heterocyclic compounds, perhaps this new drug design that will invade the different diseases in the future.We have suggested from this current report that strict crop promotion and marketing of Rhazya throughout the world may prove to be an invaluable alternative non - conventional medicinal sources.

Table 1: Rhazya stricta antimicrobial compound ‘Tetra hydro secamine’ target prediction and drug similarity [21].

Lupinepublishers-openaccess-Biostatistics-Biometrics-journal

Table 2: Rhazya stricta antimicrobial compound ‘Rhazimanine’ target prediction and drug similarity [20].

Lupinepublishers-openaccess-Biostatistics-Biometrics-journal

Table 3: Rhazya stricta antimicrobial compound ‘Akuammidine’ target prediction and drug similarity [21].

Lupinepublishers-openaccess-Biostatistics-Biometrics-journal

Table 4: Rhazya stricta antimicrobial compound ‘Stemmadenine’ target prediction and drug similarity [21].

Lupinepublishers-openaccess-Biostatistics-Biometrics-journal

Acknowledgment

The authors would like to thank the Center for Scientific and Medical Research, for allowing access to their laboratory. The authors also thank the staff and students at the University of Jeddah, Jeddah, Saudi Arabia.

References

  1. Baeshen NA, Elkady AI, Abuzinadah OA, Mutwakil MH (2012) Potential anticancer activity of the medicinal herb, Rhazya stricta, against human breast cancer. African Journal of Biotechnology 11(37): 8960-8972.
  2. Redwan EM, El-Baky NA, Al-Hejin AM, Baeshen MN, Almehdar HA, et al. (2016) Significant antibacterial activity and synergistic effects of camel lactoferrin with antibiotics against methicillin-resistant Staphylococcusaureus (MRSA). Research in microbiology 167(6): 480-491.
  3. Baeshen NA, Sabir JS, Abo-Aba SE, Qari SH, Arabia S (2009) Evaluation of the cytogenetic status and DNA integrity of human lymphocytes after exposure to an aqueous extract of Rhazya stricta leaves in vitro. Journal of Applied Sciences Research 5(8): 986-994.
  4. Baeshen NA, Elkady AI, Yaghmoor SS, Al Ashmaoi HM, Kumosani TA (2014) Evaluation of the cytotoxicity and genotoxicity of alkaloid-rich and alkaloid-free aqueous extracts of Rhazya stricta Bothalia J 44(5): 358À371.
  5. Alagrafi FS,Alawad AO, Abutaha NM, Nasr FA, Alhazzaa OA, et al. (2017)In vitro induction of human embryonal carcinoma differentiation by a crude extract of Rhazya stricta. BMC complementary and alternative medicine 17(1): 342.
  6. Khan R, Baeshen MN, Saini KS, Bora RS, Al-Hejin AM, et al. (2016)Antibacterial activities of Rhazya stricta leaf extracts against multidrug-resistant human pathogens. Biotechnology & Biotechnological Equipment 30(5): 1016-1025.
  7. Baeshen NA, Baeshen MN, Sheikh A, Bora RS, Ahmed MMM, et al. (2014) Cell factories for insulin production. Microbial cell factories 13(1): 141.
  8. El-Kady MF, Kaner RB(2013) Scalable fabrication of high-power graphene micro-supercapacitors for flexible and on-chip energy storage. Nature communications 4: 1475.
  9. Gu Z, Zakarian A (2010) Total synthesis of rhazinilam: Axial to point chirality transfer in an enantiospecific Pd-catalyzed transannular cyclization. Organic letters 12(19): 4224-4227.
  10. Gilani SA, Kikuchi A, Shinwari ZK, Khattak ZI, Watanabe KN (2007) Phytochemical, pharmacological and ethnobotanical studies of Rhazya stricta Decne. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives 21(4): 301-307.
  11. Elkady AI, Hussein RAEH, Abu-Zinadah OA (2014) Effects of crude extracts from medicinal herbs Rhazya stricta and Zingiberofficinale on growth and proliferation of human brain cancer cell line in vitro. BioMed research international.
  12. Ali BH, Alqarawi AA, Bashir AK, Tanira MO (2000) Antioxidant action of extract of the traditional medicinal plant Rhazya stricta Decne. in rats. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives 14(6): 469-471.
  13. Baeshen N, Lari S, Al Doghaither HA, Ramadan HA (2010) Effect of Rhazya stricta extract on rat adiponectin gene and insulin resistance. J American Sci 6: 1237-1245.
  14. Ali BH, Bashir AK, Banna NR, Tanira MOM (1995) Central nervous system activity of Rhazya stricta (Decne) in mice. Clinical and experimental pharmacology and physiology 22(4): 248-253.
  15. Turski L, Stephens DN (1993) Effect of the beta-carboline abecarnil on spinal reflexes in mice and on muscle tone in genetically spastic rats: A comparison with diazepam. Journal of Pharmacology and Experimental Therapeutics 267(3): 1215-1220.
  16. Elkady AI, Hussein RA, El-Assouli SM (2016) Harmal extract induces apoptosis of HCT116 human colon cancer cells, mediated by inhibition of nuclear factor-κB and activator protein-1 signaling pathways and induction of cytoprotective genes. Asian Pac J Cancer Prev 17(4): 1947-1959.
  17. Ahmad A, Wei Y, Ullah S, Shah SI, Nasir F, et al. (2017) Synthesis of phytochemicals-stabilized gold nanoparticles and their biological activities against bacteria and Leishmania. Microbial pathogenesis 110: 304-312.
  18. Al-Dabbagh B, Elhaty IA, Al Sakkaf R, El-Awady R, Ashraf SS, et al. (2018) Antioxidant and anticancer activities of Trigonellafoenum-graecum, Cassia acutifolia and Rhazya stricta. BMC complementary and alternative medicine 18(1): 240.
  19. Iqbal W, Alkarim S, Kamal T, Choudhry H, Sabir J, et al. (2019) Rhazyaminine from Rhazya stricta Inhibits Metastasis and Induces Apoptosis by Downregulating Bcl-2 Gene in MCF7 Cell Line. Integrative cancer therapies 18: 1534735418809901.
  20. Nickel J, Gohlke BO, Erehman J, Banerjee P, Rong WW, et al. (2014) SuperPred: update on drug classification and target prediction. Nucleic acids research 42(W1): W26-W31.
  21. Gfeller D, Grosdidier A, Wirth M, Daina A, Michielin O, et al. (2014) SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic acids research 42(W1): W32-W38.
  22. Zeng F, Zhang S, Hao Z, Duan S, Meng Y, et al. (2018) Efficient strategy for introducing large and multiple changes in plasmid DNA. Scientific reports 8(1): 1714.
  23. Lin Y, Bogdanov M, Lu S, Guan Z, Margolin W, et al. (2018) The phospholipid-repair system LplT/Aas in Gram-negative bacteria protects the bacterial membrane envelope from host phospholipase A2 Journal of Biological Chemistry 293(9): 3386-3398.
  24. Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are there?. Nature reviews Drug discovery 5(12): 993-996.

https://www.high-endrolex.com/21